Development of clinically viable non-muscle myosin II small molecule inhibitors
{{output}}
Non-muscle myosin II (NMII), a molecular motor that regulates critical processes such as cytokinesis and neuronal plasticity, has substantial therapeutic potential. However, translating this potential to in vivo use has been hampered by a lack of selective too... ...
